Kaprex
This product has been discontinued. Label data shown is from the last available version.
View current version →Product Information
- Brand
- Metagenics
- Form
- Softgel Capsule
- Servings Per Container
- 20
- Product Type
- Other Combinations
- DSLD Entry Date
- 2019-12-22
Target Groups
Label Statements
Formulation re: Other
Kaprex provided a plant-based option for effective joint comfort. This proprietary combination of selected plant components influences kinase signaling and the formation of certain substances, such as PGE2, that are associated with minor discomfort. Clinical testing suggests that Kaprex may offer a high degree of predicted cardiovascular, gastric, renal, and liver safety.
Suggested/Recommended/Usage/Directions
Directions: Take one softgel two times daily with food or as directed by your healthcare practitioner.
Formulation re: Does NOT Contain
This product is non-GMO and gluten-free.
Precautions re: Pregnant or Nursing or Prescription Medications
Caution: Do not use if pregnant or nursing, or taking anticoagulants. If taking other medication, consult your healthcare practitioner before use.
Precautions re: Children
Keep out of the reach of children.
FDA Disclaimer Statement
This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Formulation re: Other
Selective kinase response modulators for joint comfort
FDA Statement of Identity
Dietary Supplement
General Statements: All Other Content
Practitioner exclusive
Precautions re: Allergies
This product is manufactured in a facility that produces products containing soy, dairy, egg, nuts, fish, and crustacean shellfish.
Brand IP Statement(s) re: (c), (TM), (SM)
U.S. Patent Nos. 7,205,151; 7,195,785; 7,270,835; 7,332,185.
Supplement Facts Panel
* Percent Daily Values are based on a 2,000 calorie diet.
† Daily Value not established.